Ollyy / Shutterstock.com
30 June 2015Americas

Jazz takes on Watson at New Jersey court to protect Xyrem

Jazz Pharmaceuticals has sued Watson Laboratories for patent infringement in order to stop the company making a generic version of its flagship product Xyrem (sodium oxybate).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk